Edition:
United States

Insider Trading: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

31.77USD
13 Jan 2017
Change (% chg)

$-0.01 (-0.03%)
Prev Close
$31.78
Open
$31.80
Day's High
$32.35
Day's Low
$31.10
Volume
1,919,707
Avg. Vol
2,606,625
52-wk High
$42.49
52-wk Low
$16.64

BAKER BROS ADVISORS L P
Trading Date Type Shares Traded Price Shares Held
9 Aug 2016 Buy 1,169,877 $33.00 25,819,768
9 Aug 2016 Buy 133,153 $33.00 25,819,768
31 Mar 2016 Buy 262,253 $28.55 44,794,746
31 Mar 2016 Buy 28,647 $28.55 44,794,746
31 Mar 2016 Buy 1,182 $27.82 44,794,746
31 Mar 2016 Buy 10,818 $27.82 44,794,746
30 Mar 2016 Buy 60,587 $27.56 44,794,746
30 Mar 2016 Buy 6,618 $27.56 44,794,746
30 Mar 2016 Buy 19,676 $26.49 44,794,746
30 Mar 2016 Buy 318,969 $27.72 44,794,746
30 Mar 2016 Buy 1,467 $26.29 44,794,746
30 Mar 2016 Buy 13,433 $26.29 44,794,746
30 Mar 2016 Buy 1,614 $25.61 44,794,746
30 Mar 2016 Buy 180,122 $26.49 44,794,746
30 Mar 2016 Buy 34,844 $27.72 44,794,746
30 Mar 2016 Buy 28,433 $26.55 44,794,746
30 Mar 2016 Buy 3,106 $26.55 44,794,746
30 Mar 2016 Buy 14,775 $25.61 44,794,746
29 Mar 2016 Buy 37,882 $25.98 44,794,746
29 Mar 2016 Buy 408,607 $25.92 44,794,746
29 Mar 2016 Buy 16,057 $26.35 44,794,746
6 Jan 2016 Buy 785,045 $29.00 23,067,648
6 Jan 2016 Buy 1,801,161 $29.00 23,067,648

Institutional Holders

% Shares Owned: 99.24%
# of Holders: 335
Total Shares Held: 120,194,394
3 Mo. Net Change: 49,053
# New Positions: 8
# Closed Positions: 5
# Increased Positions: 15
# Reduced Positions: 12
# Net Buyers: 3

Officers & Directors

Name Age Since Current Position

Stephen Biggar

45 2016 Chairman of the Board

Stephen Davis

55 2016 President, Chief Executive Officer, Director

Todd Young

44 2016 Chief Financial Officer, Executive Vice President, Principal Financial Officer and Principal Accounting Officer

Glenn Baity

46 2014 Executive Vice President, General Counsel, Secretary

Terrence Moore

61 2013 Executive Vice President, Chief Commercial Officer

Srdjan Stankovic

59 2015 Executive Vice President, Head - Research and Development

Julian Baker

50 2015 Director

James Daly

2016 Director

Edmund Harrigan

63 2015 Director

Laura Brege

58 2008 Independent Director

Daniel Soland

58 2015 Independent Director

Lisa Barthelemy

2015 Senior Director, Investor Relations